Understanding Carcinoma in Situ
Presented by: Dr. Peter Black In this webinar, we will discuss what CIS is, how it is different from other types of bladder cancer and why this early stage of bladder cancer needs to be treated aggressively.
▶︎
What is Immunotherapy? | Bladder Cancer Canada
▶︎
What's in your Bladder Cancer Pathology Report?
▶︎
BCG Explained: From Treatment Basics to Side Effects
▶︎
Management of Non-Muscle Invasive Bladder Cancer
▶︎
A Dummies Guide to Bladder Cancer Diagnosis
▶︎
From Surgery to Recovery: Advocating for Yourself Through Bladder Cancer
▶︎
Staging and Standards of Care for Non Muscle Invasive Bladder Cancer
▶︎
Bladder and Testes Slide Session with Dr. Jennifer Gordetsky
▶︎
I Had No Symptoms - Margo | Bladder Cancer | The Patient Story
▶︎
Controversies in Non-muscle Invasive Bladder Cancer (NMIBC): Guidelines and Beyond 2023
▶︎
Bladder Cancer Treatment: Potential Side Effects and Toxicity
▶︎
Breakthroughs in Prostate and Bladder Cancer Treatment - Full Video
▶︎
Muscle Invasive Bladder Cancer
▶︎
GU Pathology: Bladder
▶︎
Bladder Cancer Guide
▶︎
UW Pathology Grand Rounds - Dr. Michael Haffner - Histomorphological Clues in Prostate Cancer
▶︎
Navigating Bladder Cancer Recurrence: Surveillance and Beyond | Part I
▶︎
Bladder Cancer Explained: Risk Factors, Symptoms & Treatment
▶︎
Bladder Cancer - 9 - 5-year Update
▶︎